Actuate Therapeutics Inc
Status: Publicly traded
Direct answer
Actuate Therapeutics Inc is publicly traded on NASDAQ under the ticker ACTU.
Actuate Therapeutics, Inc. is a biopharmaceutical firm operating at the clinical stage, dedicated to creating treatments for various cancers. Its primary drug candidate is Elraglusib Injection, an innovative glycogen synthase kinase-3 (GSK-3) inhibitor designed to combat metastatic pancreatic ductal adenocarcinoma. Furthermore, Elraglusib is being developed to address other malignancies, including Ewing sarcoma,...
Can you invest in Actuate Therapeutics Inc?
Yes. Actuate Therapeutics Inc trades publicly on NASDAQ as ACTU.
View deeper analysis
View detailed research on MarketSnap, including financials, valuation tools, and analyst context.
Open research for Actuate Therapeutics Inc
Detailed equity research is provided by MarketSnap.